Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease

Experimental Gerontology

Volumn 46, Issue 7, 2011, Pages 517-523

  Guarner Lans, Verónica ^a   Rubio Ruiz, María Esther ^a   Pérez Torres, Israel ^a   Baños de MacCarthy, Guadalupe ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Aging; Cardiovascular disease; Metabolic syndrome; Sexual hormones

Indexed keywords

ADIPONECTIN; ALBUMIN; ALDOSTERONE; ANGIOTENSIN; BETA CATENIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FOLLITROPIN; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; GONADORELIN; GROWTH HORMONE; INSULIN; LEPTIN; LUTEINIZING HORMONE; MELATONIN; PHOSPHATIDYLINOSITOL 3 KINASE; PRASTERONE; PROTEIN KINASE B; RENIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SIRTUIN 1; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN;

AGING; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; FEMALE; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFESPAN; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GONADAL STEROID HORMONES; HUMANS; HYPERTENSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; PITUITARY-ADRENAL SYSTEM; SEX FACTORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 79956299010     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2011.02.007     Document Type: Review

References (69)

1. Ackermann M., Pletcher S.D. Evolutionary biology as a foundation for studying aging and aging-related diseases. Evolution in Health and Disease 2008, 241-252. Oxford University Press. Second edition. S.C. Stearns, J.C. Koella (Eds.).
2. Anisimov V.N. Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention. Exp. Gerontol. 2003, 38(10):1041-1049.
3. Anisimov V.N. Role of the growth hormone-insulin-like growth factor-1-insulin system signaling in aging and longevity: evolutional aspect. Ross. Fiziol. Zh. Im. IM Sechenova 2008, 94(9):1092-1109.
4. Arnlov P., Pencina M.J., Amin S., Nam B.H., Benjamin E.J., Murabito M.J., Wang T., Knapp P.E., D́Agostino R.B., Bhasin S., Vasan P.S. Endogenous hormones and cardiovascular disease in men. Ann. Intern. Med. 2006, 145(3):176-184.
5. Austad S.N., Finch C.E. The evolutionary context of human aging and degenerative disease. Evolution in Health and Disease 2008, 301-311. Oxford University Press. Second edition. S.C. Stearns, J.C. Koella (Eds.).
6. Bauer M.E. Stress, glucocorticoids and ageing of the immune system. Stress 2005, 8(1):69-83.
7. Baumgartner R.N., Waters D.L., Gallagher D., Morley J.E., Garry P.J. Predictors of skeletal muscle mass in elderly men and women. Mech. Ageing Dev. 1999, 107(2):123-136.
8. Baylis C. Sexual dimorphism in the aging kidney: differences in the nitric oxide system. Nat. Rev. Nephrol. 2009, 5(7):384-396.
9. Bhupathy P., Haines C.D., Leinwald L.A. Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond. Engl.) 2010, 6(1):77-95.
10. Bjórntrop P. Do stress reactions cause abdominal obesity and comorbidities. Obes. Rev. 2001, 2(2):73-86.
11. Blum W.F., Englaro P., Hanitsch S., Juul A., Hertel N.T., Müller J., Skakkebaek N.E., Heiman M.L., Birkett M., Attanasio A.M., Kiess W., Rascher W. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J. Clin. Endocrinol. Metab. 1997, 82(9):2904-2910.
12. Böttner A., Kratzsch J., Müller G., Kapellen T.M., Blüher S., Keller E., Blüher M., Kiess W. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J. Clin. Endocrinol. Metab. 2004, 89(8):4053-4061.
13. Butcher S.K., Lord J.M. Stress responses and innate immunity: aging as a contributory factor. Aging Cell 2004, 3(4):151-160.
14. Calabrese V., Cornelius C., Mancuso C., Pennisi G., Calafato S., Bellia F., Bates T.E., Stella A.M.G., Schapira T., Dinkova Kostova A.T., Rizzarelli E. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem. Res. 2008, 33:2444-2471.
15. Chow U.T.K., Phoon M.C. Measurement of serum leptin concentrations in university undergraduates by competitive ELISA reveals correlations with body mass index and sex. Adv. Physiol. Educ. 2003, 27:70-77.
16. Clegg D.J., Brown L.M., Woods S.C., Benoit D.C. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006, 55:978-987.
17. Da Silva J.A. Sex hormones and glucocorticoids: interactions with the immune system. Ann. NY Acad. Sci. 1999, 876:102-117.
18. Dale E., Davis M., Faustman D.L. A role for transcription factor NF-κB in autoimmunity: possible interactions of genes, sex, and the immune response. Adv. Physiol. Educ. 2006, 30:152-158.
19. de Martinis M., Franceschi C., Monti D., Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 2005, 579(10):2035-2039.
20. Ding E.L., Song Y., Malik V.S., Liu S. Sex differences of endogenous sex hormones and risk of type-2 diabetes: a systematic review and meta-analysis. JAMA 2006, 295(11):1288-1299.
21. Escrivá F., Gavete M.L., Fermín Y., Pérez C., Gallardo N., Alvarez C., Andrés A., Ros M., Carrascosa J.M. Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity. J. Endocrinol. 2007, 194(1):131-141.
22. Fliers E., Kreier F., Voshol P.J., Havekes L.M., Sauerwein H.P., Kalsbeek A., Buijs R.M., Romijn J.A. White adipose tissue: getting nervous. J. Neuroendocrinol. 2003, 15:1005-1010.
23. Forman J.P., Williams J.S., Fisher N.D.L. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010, 55:1283-1288.
24. Gao Q., Horvath T.L. Cross-talk between estrogen and leptin signaling in the hypothalamus. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E817-E826.
25. Garcia-Segura L.M., Diaz-Chaves Y., Perez-Martin M., Darnaudéry M. Estradiol, insulin-like growth factor-I and brain aging. Psychoneuroendocrinology 2007, 32(Suppl 1):S57-S61.
26. Giani J.F., Mayer M.A., Muñoz M.C., Silberman E.A., Höcht C., Taira C.A., Gironacci M.M., Turyn D., Dominici F.P. Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E262-E271.
27. Greenfield J.R., Campbell L.V. Relationship between inflammation, insulin resistance and type-2 diabetes: 'cause or effect'?. Curr. Diab. Rev. 2006, 2(2):195-211.
28. Guarner V., Carbó R., Rubio M.E., Baños de MacCarthy G. Aging of the cardiovascular system. Hypertension: New Research 2005, 47-68. Nova Biomedical Books, USA. E.F. Benhagen (Ed.).
29. Haring R., Volzke H., Felix S.B., Schipf S., Dorr M., Rosskopf D., Nauck M., Schofl C., Wallaschafski H. Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 2009, 58(9):2027-2031.
30. Henriksen E.J. Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293(3):R974-R980.
31. Huang P.L. A comprehensive definition for metabolic syndrome. Dis. Models Mech. 2009, 2:231-273.
32. Kaaja R.J., Pöyhönen-Alho M.K. Insulin resistance and sympathetic overactivity in women. J. Hypertens. 2006, 24(1):131-141.
33. Kirkwood T.B. Genes that shape the course of ageing. Trends Endocrinol. Metab. 2003, 14:345-347.
34. Kolovou G.D., Bilianou H.G. Influence of aging and menopause on lipids and lipoproteins in women. Angiology 2008, 59(2 Suppl):54S-57S.
35. Kolthur-Seetharam U., Teerds K., de Rooij D.G., Wendling O., McBurney M., Sassone-Corsi P., Davidson I. The histone deacetylase SIRT1 controls male fertility in mice through regulation of hypothalamic-pituitary gonadotropin signaling. Biol. Reprod. 2009, 80:384-391.
36. Krier F., Fliers E., Voshol P.J., Van Eden C.G., Havekes L.M., Kalsbeek A., Van Heijningen C., Sluiter A.A., Mettenleiter T.C., Romijn J.A., Sauerwein H.P., Buijs R.M. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J. Clin. Investig. 2002, 110:1243-1250.
37. Lambert E., Straznicky N., Eikelis N., Esler M., Dawood T., Masuo K., Schlaich M., Lambert G. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J. Hypertens. 2007, 25(7):1411-1419.
38. Lopez-Ruiz A., Sartori-Valinotti J., Yanes L.L., Iliescu R., Reckelhoff J.F. Sex differences in control of blood pressure: role of oxidative stress in hypertension in females. Am. J. Physiol. Heart Circ. Physiol. 2008, 295(2):H466-H474.
39. Luczak E.D., Leinwand L.A. Sex-based cardiac physiology. Annu. Rev. Physiol. 2009, 71:1-18.
40. Lunenfeld B. Endocrinology of the aging male. Minerva Ginecol. 2006, 58(2):153-170.
41. Magwere T., Chapman T., Partridge L. Sex differences in the effect of dietary restriction on life span and mortality rates in female and male Drosophila melanogaster. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59(1):3-9.
42. Maturana M.A., Breda V., Lhullier F., Spritzer P.M. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism 2008, 57(7):961-965.
43. Mesch V.R., Siseles N.O., Maidana P.N., Boero L.E., Sayegh F., Prada M., Royer M., Schreier L., Benencia H.J., Berg G.A. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 2008, 11(6):509-517.
44. Michelson, R.M., 2000. Hypertension in the elderly. 1st virtual Congress of Cardiology. http://www.fac.org.ar/cvirtual/cvirteng/cienteng/fgeng/fgc4200i/imichels.htm.
45. Monroe M.B., Van Pelt R.E., Schiller B.C., Seals D.R., Jones P.P. Relation of leptin and insulin to adiposity-associated elevations in sympathetic activity with age in humans. Int. J. Obes. Relat. Metab. Disord. 2000, 24(9):1183-1187.
46. Muller M., Grobbee D.E., den Tonkelaar I., Lamberts S.W., van der Schouw Y.T. Endogenous sex hormones and metabolic syndrome in aging men. J. Clin. Endocrinol. Metab. 2005, 90(5):2618-2623.
47. Narkiewicz K., Phillips B.G., Kato M., Hering D., Bieniaszewski L., Somers V.K. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 2005, 45(4):522-525.
48. Pasquali R., Vicennati V., Gambineri A., Pagotto U. Sex-dependent role of glucocorticoids and androgens in the pathophysiology ofhuman obesity. Int. J. Obes. (Lond) 2008, 32(12):1764-1779.
49. Power M.L., Schulken J. Sex differences in fat storage, fat metabolism and the health risks from obesity: possible evolutionary origins. Br. J. Nutr. 2008, 99(5):931-940.
50. Pralong F.P., Gaillard R.C. Neuroendocrine effects of leptin. Pituitary 2001, 4(1-2):25-32.
51. Qiang W., Weiqiang K., Qing Z., Pengju Z., Yi L. Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPK alpha. Exp. Mol. Med. 2007, 39(4):535-543.
52. Qiao X., McConnell K.R., Khalil R.A. Sex steroids and vascular responses in hypertension and aging. Gend. Med. 2008, 5(Suppl A):S46-S64.
53. Ramírez-Expósito M.J., Martínez-Martos J.M. Hypertension, RAS, and gender: what is the role of aminopeptidases?. Heart Fail. Rev. 2008, 13(3):355-365.
54. Rivard A., Principe N., Andres V. Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells. A potential link between aging, smooth muscle cell proliferation and atherosclerosis. Cardiovasc. Res. 2000, 45(4):1026-1034.
55. Rubio M.E., Baños G., Díaz E., Guarner V. Effect of age on insulin-induced endothelin release and vasoreactivity in hyperglyceridemic and hypertensive rats. Exp. Gerontol. 2006, 41:282-288.
56. Shabsigh R., Arver S., Channer K.S., Eardley I., Fabbri A., Gooren L., Heufelder A., Jones H., Meryn S., Zitzmann M. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int. J. Clin. Pract. 2008, 62(5):791-798.
57. Shaposhnikov M.V. Life span sexual dimorphism. Adv. Gerontol. 2008, 21(3):507-509.
58. Simoncini T., Maffei S., Basta G., Barsacchi G., Genazzani A.R., Liao J.K., de Caterina R. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ. Res. 2000, 87:19-25.
59. Skouby S.O., Sidelmann J.J., Nilas L., Gram J., Jespersen J. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors. Climacteric 2008, 11(6):489-497.
60. Sowers R.J. Insulin resistance and hypertension. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H1597-H1602.
61. Tank J., Heusser K., Diedrich A., Hering D., Luft F.C., Busjahn A., Narkiewicz K., Jordan J. Influences of gender on the interaction between sympathetic nerve traffic and central adiposity. J. Clin. Endocrinol. Metab. 2008, 93(12):4974-4978.
62. Tsou P.L., Jiang Y.D., Chang C.C., Wei J.N., Sung F.C., Lin C.C., Chiang C.C., Tai T.Y., Chuang L.M. Sex-related differences between adiponectin and insulin resistance in schoolchildren. Diabetes Care 2004, 27(2):308-313.
63. Unger R.H. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol. Metab. 2003, 14(9):398-403.
64. Unger R.H. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol. Metab. 2003, 14(9):398-403.
65. Wu D., Ren Z., Pae M., Guo W., Cui X., Merrill A.H., Meydani S.N. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. J. Immunol. 2007, 179(7):4829-4839.
66. Yanes L.L., Romero D., Cucchiarelli V., Fortepiani L.A., Gomez-Sanchez C., Santacruz F., Reckelhoff J.F. Role of endothelin in mediating postmenopausal hypertension in a rat model. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288:R229-R233.
67. Yeap B.B. Are declining testosterone levels a major risk factor for ill-health in aging men?. Int. J. Impot. Res. 2009, 21(1):24-36.
68. Yeap B.B. Testosterone and ill-health in aging men. Nat. Clin. Pract. Endocrinol. Metab. 2009, 5(2):113-121.
69. Zhang J. The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation. J. Biol. Chem. 2007, 282(47):34356-34364.